Scientists test if radiation timing boosts Cancer-Fighting power of immunotherapy

NCT ID NCT03223155

Summary

This study is testing the safety of combining two immunotherapy drugs with a precise form of radiation in patients with advanced lung cancer that has spread. The main goal is to find the safest radiation dose for different body areas and to see if giving the radiation at the same time as the immunotherapy works better or is safer than giving it first. Researchers will also check if this combination helps control the cancer and how it affects the body's immune response.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for STAGE IV SMALL CELL LUNG CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • University of Chicago

    Chicago, Illinois, 60637, United States

Conditions

Explore the condition pages connected to this study.